Key facts
- Ecovia Bio’s last known valuation is $26.0M (Feb 2026).
- It has raised $16.0M; the latest was Later Stage VC ($3.0M) in Feb 2026.
- Notable investors include US National Science Foundation, U.S. Department of Energy, Keiretsu Forum, United States Department of Agriculture, Invest Detroit Ventures — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Ecovia Bio
- ·The full record, as it builds
Funding rounds
No funding rounds for Ecovia Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ecovia Bio
Developer of bio-based chemicals and fuels designed to develop farming ingredients and materials from sustainable processes. The company's suite of biopolymers is made from a proprietary fermentation process, and its water-soluble and water-swellable polymer products are based on polyglutamic acid, thereby enabling farmers to have biodegradable, and functional alternatives to conventional acrylate and acrylamide polymers and starch-based biopolymers.
- Sector
- Materials and Resources
- HQ
- Livonia, MI, United States
- Founded
- 2014
- Employees
- 10
- Website
- ecovia-bio.com/
- Ownership
- Privately Held (backing)
Ecovia Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ecovia Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ecovia Bio in its N-PORT filings yet. We sweep new filings monthly.